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Abstract Inactivation of the chloride channel cystic fibro-
sis transmembrane conductance regulator (CFTR) causes
cystic fibrosis (CF). Although CFTR is expressed in the
kidney, no overwhelming renal phenotype is associated
with CF. Recent studies have shown that the level of CFTR
mRNA in mouse kidney approaches that found in lung.
CFTR is particularly abundant in the apical area of
proximal tubule cells, where it co-distributes with the Cl−/
H+ exchanger ClC-5 and Rab5a in endosomes. The
biological relevance of CFTR in proximal tubule endocy-
tosis has been tested in CF mouse models and CF patients.
Mice lacking CFTR show a defective receptor-mediated
endocytosis, as evidenced by impaired uptake of 125I-β2-
microglobulin, a decreased expression of the cubilin
receptor in the kidney, and a significant excretion of cubilin
and its low-molecular-weight ligands into the urine. Low-
molecular-weight proteinuria (and particularly transferrinuria)
is similarly detected in CF patients in comparison with normal
controls or patients with chronic lung inflammation. These
studies suggest that the functional loss of CFTR impairs the
handling of low-molecular-weight proteins by the kidney,
supporting a role of CFTR in receptor-mediated endocytosis
in proximal tubule cells. The selective proteinuria should be
integrated in the pathophysiology of multi-systemic compli-
cations increasingly observed in CF patients.
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Cystic fibrosis: pathology and genetics
Cystic fibrosis (CF, OMIM #219700) is the most common
lethal autosomal recessive disease in Caucasians, affecting
as many as one in 2,500 live births. Cystic fibrosis is a
multisystemic disease that essentially results from the
obstruction of exocrine glands by an excessive mucus
production. The accumulation of thick mucus in the human
airways causes obstructive lung disease promoting chronic
bacterial infection and inflammation, the hallmark of CF. A
similar mucus accumulation in pancreatic ducts, bile ducts,
and the intestine may lead to pancreatic insufficiency, liver
damage, and meconium ileus (intestinal obstruction),
respectively, in some patients with CF [73]. In addition,
the absence or obstruction of the vas deferens causes male
infertility in most CF patients, and altered cervical mucus
production reduces female fertility [55]. The airway
manifestations represent the main cause of morbidity and
mortality in CF patients. Nowadays, improvement in
medical care often preserves life expectancy beyond the
third decade [73].
The fact that patients with CF have a typically high
concentration of NaCl in the sweat, coupled with an
increased lumen-negative transepithelial voltage, pointed
early on to a defective chloride transport and salt
homeostasis as the cause of organ damage in CF [73, 79].
In 1989, Collins, Riordan and colleagues demonstrated that
CF was due to loss-of-function mutations in the CFTR gene
that encodes a Cl− channel named CFTR—for cystic
fibrosis transmembrane conductance regulator [48, 71].
The CFTR gene, also named as ABCC7, is located on
chromosome 7q31.2 and spans approximately 290 kb of
genomic DNA (27 exons) encoding a 1,480-amino acid
protein [20]. Over 1,000 CF-associated mutations have
been reported thus far in CFTR (CF Genetic Analysis
Consortium, http://www.genet.sickkids.on.ca/cftr/) and
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have been classified into five groups according to their
structural or functional consequences on Cl− conduction
[73]. The in-frame deletion of three bases encoding a
phenylalanine residue at position 508 (ΔF508) represents
the most common mutation in CF population, affecting the
correct processing and maturation of CFTR [5]. About 5%
to 10% of CFTR mutations are due to premature truncation
or non-sense alleles and are associated with the most severe
CF phenotypes [74]. Most other CFTR defects are unique
to a particular family or to only a handful of cases across
the world. The type of CFTR mutations seems directly
linked to the pancreatic phenotype, whereas the high
variability in pulmonary complications among siblings
carrying identical mutations strongly supports the influence
of the environment and modifier genes in the disease
severity [74]. Moreover, patients with the CF phenotype
have been reported with no or only one mutation in the
CFTR gene [29]. These cases exemplify the broad clinical
spectrum of CFTR-linked disease and support the existence
of additional genes involved in the CF phenotype.
Structure and function of CFTR
The CFTR protein is a member of the adenosine triphosphate
(ATP)-binding cassette (ABC) superfamily of integral mem-
brane transporters [25]. The ABC transporters function as
mediators of unidirectional organic solute transport and
include multidrug resistance proteins, such as MDR and P-
glycoprotein, and a number of prokaryotic and eukaryotic
small nutrient and molecule transporters [38]. CFTR is
organized symmetrically in two transmembrane domains
(TMD1 and TMD2) and two nucleotide binding domains
(NBD1 and NBD2), separated by a large, polar, regulatory
(R) domain unique within the ABC family [71]. Each
membrane-spanning domain contains six α helices, portions
of which form the Cl− pore. CFTR is regulated by cyclic
adenosine monophosphate (cAMP)-dependent phosphoryla-
tion of the R domain via protein kinase A (PKA), followed
by ATP-dependent gating events initiated by ATP binding to
the cytoplasmic nucleotide-binding domains (NBD1 and
NBD2) and resulting in transepithelial Cl− transport [25, 79].
The N and C termini of CFTR are both intracellularly
oriented. The C terminus harbors a conserved type I PDZ
domain-binding motif, which interacts with several PDZ-
domain proteins including the Na+/H+ exchange regulatory
factors (NHE-RF1 and NHE-RF2) and the actin-binding
protein ezrin [31]. The dynamic regulation of CFTR
binding to such scaffolding proteins may determine its
dimeric organization into macromolecular functional units
containing regulatory partners and other channels. Further-
more, the phosphorylation of the R domain is also regulated
by NHERF1, NHERF2, and ezrin [32]. The insertion of
CFTR channels in the plasma membrane also involves a
complex of proteins including the PDZ-domain proteins
NHERF1 and CAL as well as the SNARE SYN6 and the
Rho GTPase TC10 [6]. Consequently, molecular switches
regulate CFTR-mediated Cl− secretion by modulating both
its channel activity and its intracellular trafficking [52]. On
the other hand, PKA is involved in the exocytic insertion and
endocytic retrieval of CFTR from the plasma membrane and
distinct Rab GTPases, which are small catalysts responsible
for cargo selection, vesicle motility, and endosome docking
and fusion to the appropriate membranes, participate in the
intracellular transport and the plasma membrane localization
of CFTR [32]. CFTR interacts functionally with other
channels, including the outwardly rectifying Cl− channels
and the Na+ channel ENaC, and it participates in exocytosis
and the formation of macromolecular complexes at the
plasma membrane, in close contact with receptors, signaling
proteins, and the cytoskeleton [32]. Therefore, the role of
CFTR extends well beyond Cl− permeability, as supported
by its unique structure and its subcellular distribution in
epithelial cells.
Segmental and subcellular distribution of CFTR
in the kidney
CFTR is located in the apical membrane of numerous
secretory epithelia, including airways, colonic crypts,
pancreatic and sweat ducts, and male genital tract [79].
However, several studies have demonstrated the expression
of CFTR in the developing and mature mammalian kidney
[12, 15, 43, 58]. CFTR mRNA is detected in all nephron
segments of the rat and human kidney, but is particularly
abundant in the cortex and outer medulla [58]. By
immunostaining, CFTR was detected at the apical surface
of both proximal and distal tubules of rat kidney but not in
the outer medullary collecting ducts [12]. Recent studies in
mouse kidney [43] revealed that CFTR is mainly expressed
in the apical area of proximal tubular (PT) cells (pars recta,
S3 segment; Fig. 1a), with a subcellular distribution
compatible with endosomes as shown by co-distribution
with ClC-5 and vacuolar H+-ATPase (V-ATPase) in Rab5a-
enriched fractions (Fig. 1b). In the human kidney, CFTR
protein expression was detected in the PT, in addition to the
thin limbs of Henle’s loop, distal tubules, and collecting
ducts [12, 15, 58]. CFTR is also expressed in the branching
ureteric bud during early nephrogenesis [15]. Of note, a
functional truncated isoform (TNR-CFTR) made of the
TMD1, NBD1 and R domains has also been detected in rat
and human kidney with a distinct ontogeny pattern and a
minor plasma membrane expression [15, 39, 58].
Besides its location in the plasma membrane, CFTR is
located in intracellular organelles along the endocytic and




Fig. 1 Localization of CFTR in mouse kidney. A Distribution of CFTR
in mouse kidney. (a) CFTR is detected preferentially at the junction
between the inner cortex and the outer stripe of the outer medulla
(OSOM). (b) In the cortex, CFTR is located in the apical area of
proximal tubules. (c, d) The segmental co-localization of CFTR and
AQP1 indicates that CFTR is particularly abundant in the apical area of
the distal S3 segments of the proximal tubule, just before the transition
with the descending thin limb (arrowheads). No specific staining is
observed in Cftr−/− kidney (not shown). Bars 500 μm in a; 50 μm in b;
and 100 μm in c and d. g glomerulus. B Subcellular distribution of
CFTR in mouse kidney: Percoll gradient analyses. Percoll gradients of
total mouse Cftr+/+ kidney resolve a low-density peak (fractions 2–4)
including the early endosomal maker Rab5a, an intermediate density
peak (fractions 7–9) including the brush border component villin, and a
bottom peak enriched in lysosomes (cathepsin D). Distributions after
centrifugation are presented by comparison with the initial concentration
(C/Ci values >1 reflect organelle enrichment, and values <1 reflect
organelle depletion). Typical densities are indicated by a broken line in
the lower panel. CFTR co-distributes with ClC-5 and the vacuolar H-
ATPase (E1 subunit) in the endosomal fractions. Modified from [43]
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secretory pathways, in which it might act as a pH regulator
by importing Cl− in parallel to H+ accumulation [3]. Mutant
epithelial cells derived from CF patients exhibit no cAMP-
dependent regulation of endocytosis and exocytosis, unless
transfected with cDNA encoding wild-type CFTR [4].
Incubation of freshly isolated nasal polyps from CF patients
harboring the ΔF508 mutation with 3-(2,4-dinitro-anilino)-
3′-amino-N-methyldipropylamine (DAMP), used as a semi-
quantitative marker of vesicular acidification, showed that
DAMP accumulation was significantly lowered in specific
biosynthetic compartments, i.e. trans-Golgi and pre-lyso-
somal organelles [1]. Moreover, the monitoring of mem-
brane potential in a light microsomal fraction from CF and
non-CF epithelial cells showed that acidification is limited
in CF cells by a high ΔΨ resulting from insufficient Cl−
counterion conductance. In turn, defective acidification
may induce lysosomal enzyme deficiencies and abnormal
trafficking and processing of newly synthesized polypep-
tides in cells lacking CFTR [3]. However, the role of CFTR
in regulating organelle pH remains controversial, with
hyper- rather than hypo-acidification suggested to occur in
CF respiratory epithelial cells. Indeed, cell ratiometric
imaging with luminally exposed pH-sensitive green-fluo-
rescent protein have demonstrated that CFTR decreases the
pH of endosomal organelles because of a loss of CFTR
inhibitory effects on Na+ transport and a defect in cyclic
guanosine 3,5 monophosphate signaling cascade [69]. In
addition, recycling of transferrin receptor is impaired in
CFTR mutant lung epithelial cells, with possible functional
consequences at both the plasma membrane and within
endosomal compartments [70].
The renal phenotype of cystic fibrosis
Despite the expression of CFTR in the mammalian
kidney [12, 15], no overwhelming renal phenotype is
associated with CF. Patients with CF are prone to develop
episodes of hyponatraemic, hypochloraemic dehydration
with metabolic alkalosis, resembling Bartter syndrome
[47, 81]. A reduced renal NaCl excretion and decreased
capacity to dilute and concentrate urine has also been
reported [59]. However, some of these modifications
could result from a primary defect in kidney function or
simply reflect changes in the extracellular fluid volume
caused by excessive losses of NaCl in sweat and feces.
Microscopic nephrocalcinosis has been detected in an
autopsy series of CF patients ranging in age from birth to
36 years [46], and the incidence of kidney stones in CF
patients may also be increased [27]. However, the relative
contribution of lithogenic factors, such as hypocitraturia,
hyper-oxaluria and -uricosuria, or impaired hydration
remains elusive.
In CF mouse models, renal Na+ clearance studies
showed no significant difference between controls and
Cftrtm2Cam mice harboring the ΔF508 mutation under
basal conditions or after acute extracellular volume
expansion [49]. In addition, Cftrtm2Cam ΔF508 mice were
equally able to reduce Na+ excretion under chronic dietary
salt restriction but displayed an increased amiloride
sensitivity, compatible with a functional interaction bet-
ween CFTR and the Na+ channel ENaC in collecting duct
principal cells [50, 51]. Recently, Lu et al. used CFTR-
deficient mice to demonstrate that CFTR regulates the
ATP sensitivity of the K+ channel renal outer medullary
potassium channel (ROMK) in the thick ascending limb
(TAL) of the loop of Henle, which could explain why CF
patients are prone to develop the pseudo-Bartter features
of hypokalemic metabolic alkalosis [54].
Interestingly, CF patients show an enhanced renal
clearance of many drugs including aminoglycosides [75],
which pointed to a putative defect in receptor-mediated
endocytosis in proximal tubule cells [78]. Indeed, by
analogy to other intracellular Cl− transporters such as the
Cl−/H+ exchanger, ClC-5, CFTR may play a role in
membrane recycling and/or vesicular pH regulation in
kidney cells [17]. However, until recently, the possible role
of CFTR in regulating endocytosis in kidney PT cells had
not been substantiated in mouse models or CF patients.
Receptor-mediated endocytosis in the proximal tubule
A significant amount of albumin and low-molecular-
weight (LMW) plasma proteins is continuously filtered
through the glomerular basement membrane, to be
reabsorbed by PT cells [2]. As an example, albumin
concentration in the ultrafiltrate is in the range of 20 to
30 mg/l, which corresponds to a daily filtered load of
albumin of 3.5 to 5.5 g, of which less than 1% is excreted
in the final urine [26]. By definition, LMW proteins are
characterized by a molecular mass lower than that of
albumin (∼69 kDa). They include hormones (parathor-
mone (PTH), insulin, growth hormone), carrier or storage
proteins (retinol-, vitamin D- and folate-binding pro-
teins), enzymes (cytochrome C, lysozyme), cell-surface
antigen components (β2-microglobulin), immunoglobulin
light chains, and other proteins (cystatin C, Clara cell
CC16 protein, and α1-microglobulin). Most of these
filtered LMW proteins are reabsorbed and metabolized
by PT cells, and the human urine is virtually devoid of
plasma proteins under physiological conditions (Fig. 2).
Such massive uptake of proteins accounts for as much as
80% of the total metabolic clearance of small proteins and
peptides and plays a key role in hormone and vitamin
homeostasis [7].
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The uptake of LMW proteins by PT cells essentially
involves receptor-mediated endocytosis, while fluid-phase
capture can be considered as quantitatively negligible [9].
During receptor-mediated endocytosis, filtered proteins are
concentrated at the apical cell surface, and their concentra-
tion in the endocytic invagination exceeds that in the
extracellular space several fold. Clathrin-mediated endocyto-
sis represents the predominant pathway for protein uptake
across the apical membrane of PT cells, with an endocytic
pathway consisting of five main interrelated compartments:
(1) microvilli and clathrin-coated pits, (2) early endosomes,
(3) dense apical tubules responsible for apical recycling, (4)
late endosomes, and (5) lysosomes [10]. The process
requires two multiligand receptors, megalin and cubilin, that
are abundantly expressed at the brush border of PT cells [7].
Ligand binding and interactions between both receptors
induce their internalization into coated vesicles and their
subsequent delivery to endosomes and lysosomes for ligand
processing and receptor degradation or recycling (Fig. 2).
Receptor-mediated endocytosis of albumin depends on the
integrity of the actin cytoskeleton and the microtubules [26],
whereas progression along the endocytic apparatus requires a
sustained vesicular acidification from early to late endo-
somes and finally to lysosomes [22, 80] (Fig. 3). Indeed, the
drop in pH in the successive endocytic compartments
triggers receptor–ligand dissociation and modulates vesicle
trafficking, endosomal fusion events, and coat formation
[40]. In PT cells, the endosomal acidification is driven by the
electrogenic vacuolar H+-ATPase (Fig. 4), whose inhibition
by pharmacological agents like bafilomycin A-1 or toxic
agents like the heavy metal cadmium severely impairs the
uptake of albumin and LMW proteins in vitro and in vivo
cubilin megalin
Fig. 2 Reabsorption of low-molecular-weight proteins by proximal
tubule cells. Albumin and low-molecular-weight (LMW) proteins
(including PTH, vitamin-D binding protein (DBP), and 25(OH)
vitamin D) that are naturally filtered by the glomerulus into the
primary urine are endocytosed by PT cells via the megalin–cubilin
receptor pathway. Following internalization in coated vesicles, the
receptor–ligand complexes progress along the endocytic pathway. The
endosomes undergo a progressive acidification that results in the
dissociation of the receptor–ligand complexes, with megalin and
cubilin (inset) being recycled in the apical membrane, whereas the









Fig. 3 Vesicular acidification and receptor-mediated endocytosis. The
endocytic pathway in proximal tubule cells involves coated pits and
coated vesicles, followed by early endosomes that form recycling
endosomes or mature to late endosomes and lysosomes. There is a
progressive, ATP-dependent acidification of the endosomes (pH 5 to 6)
and lysosomes (pH 4.6–5.0) that is necessary for dissociation of the
ligand–receptor complex, recycling of receptors to the apical membrane,
and progression of ligands into lysosomes. The approximate pH values of
the different compartments are indicated. Modified from [17]
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[37, 84, 86]. The translocation of H+ from the cytoplasm into
the endosomes generates a transmembrane electrical poten-
tial (ΔΨ) resulting in a rapid inhibition of V-ATPase activity.
Thus, in order to limit the formation of an endosomal-
positive membrane potential, either anions have to concur-
rently enter vesicles or cations have to leave (Fig. 4). In most
cases, acidification of intracellular vesicles seems dependent
on a parallel Cl− conductance that provides the electrical
shunt necessary to neutralize the H+ electrical gradient [42].
Furthermore, the intravesicular Cl− concentration itself could
directly affect the V-ATPase activity [60] as well as the
vesicle recycling independently of its effect on pH [22].
The paradigm of Dent’s disease
Recent investigations on the pathophysiology of Dent’s
disease and the Cl−/H+ exchanger, ClC-5, have provided
exciting information on the role of chloride transporters along
the endocytic pathway [42]. Dent’s disease (OMIM #300009)
is a rare X-linked renal tubulopathy characterized by LMW
proteinuria associated with hypercalciuria, which may
provoke nephrolithiasis, nephrocalcinosis, and renal failure
[18, 77]. Low-molecular-weight proteinuria is the most
consistent manifestation of Dent’s disease, detected in all
affected males and obligate carrier females. In contrast, there
is considerable inter- and intra-familial variability in the other
manifestations of the disease, including progression to renal
failure [77]. Dent’s disease is caused by mutations in the
CLCN5 gene that encodes ClC-5, an electrogenic Cl−/H+
exchanger [53, 66, 76]. ClC-5 belongs to the CLC family of
Cl− channels/transporters that have been discovered and
characterized by Jentsch and colleagues ([41] for review).
ClC-5 consists of 746 amino acids and forms diamond-
shaped homodimers composed of two repeated halves that
span the membrane in opposite orientation [19]. Each
subunit has its own pore responsible for the selective
coupling of the Cl− flux to H+ counter-transport [66, 76].
In vitro studies have demonstrated that natural mutations in
ClC-5 lead to a loss of function [53]. Furthermore, genetic
inactivation of the Clcn5 gene in mouse mimics the severe
PT dysfunction observed in Dent’s disease [67, 85].
The complex phenotype of Dent’s disease is probably
explained by the expression of ClC-5 in multiple nephron
segments, including the PT, the TAL, and the α-type
intercalated cells [16, 18, 33]. Particularly, ClC-5 co-
distributes with the V-ATPase in early endosomes along the
endocytic apparatus in PT cells [16, 33], where it is thought
to ensure the Cl− permeability in parallel with H+ transport
(Fig. 4), as suggested by a decreased ATP-dependent
fluorescence quenching of low-density vesicles isolated from
ClC-5-deficient mice and loaded in vitro by acridine orange
[34]. Further measurements of endosomal pH and Cl−
concentration in PT cells cultured from ClC-5-deficient mice
provided additional evidence for ClC-5 involvement in
acidification of early endosomes but not of late endosomes
and Golgi [36]. Other members of the CLC family of
vesicular channels/transporters have been shown to play a
role in vesicular acidification, including ClC-3 and ClC-7
[28, 36]. Furthermore, recent studies have demonstrated that
ClC-5 inactivation induces a generalized trafficking defect in
PT cells, with loss of megalin and cubilin at the brush border
and impaired lysosome biogenesis, which also contributes to
defective endocytosis and urinary loss of LMW ligands and
lysosomal enzymes [8, 61].
Receptor-mediated endocytosis in CFTR-deficient
mouse kidney
As mentioned above, the distribution of CFTR in the apical
endosomes of mouse PT cells [43] pointed to its possible
involvement in renal endocytosis. This hypothesis was
recently substantiated by using CF mouse models to
characterize the role of CFTR in the kidney. Plasma and
urine analyses revealed that baseline renal function was
normal in Cftr−/− (Cftrtm1Cam) mice. However, the urinary
excretion of the LMW Clara Cell protein (CC16, 16 kD)
was significantly increased in Cftr−/− mice in comparison to
controls, reflecting a defect in PT cell apical endocytosis.
This was supported by the demonstration of a significant
decrease in the renal uptake of radiolabelled 125I-β2-
microglobulin in Cftr−/− mice and a lower renal uptake of















Fig. 4 Ion transport processes involved in endosomal acidification. The
endosomal acidification is achieved by ATP-driven transport of cytosolic
H+ through the V-ATPase. The positive electrical gradient (ΔΨ) is
dissipated by cation (H+, K+, Na+) leakage, as well as by parallel Cl−
permeability through ClC-5 and most likely other anion transporters.
Recent studies have demonstrated that vesicular CLC isoforms (ClC-3
to ClC-7) act as voltage-dependent Cl−/H+ exchangers. ClC-6, restricted
to the nervous system, is not depicted. Adapted from [22]
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The endocytic uptake of aminoglycosides and LMW
proteins, like CC16 and β2-microglobulin, is mediated by
the multiligand receptors, megalin and cubilin [7]. In
contrast to megalin, which is a member of the low-density
lipoprotein receptor family, cubilin, also known as the
intestinal intrinsic factor (IF)-B12 receptor, is a highly
conserved membrane glycoprotein with little structural
homology to known endocytic receptors and is character-
ized by the absence of a transmembrane domain [2]. High-
affinity binding of purified megalin to cubilin N-terminal
region has been shown in vitro, suggesting that megalin
participates in the endocytosis and intracellular trafficking
of cubilin [57]. The apical sorting of cubilin and its
participation in receptor-mediated endocytosis critically
depend on its reciprocal interaction with the transmembrane
protein amnionless (AMN) identified as a key factor for
mouse gastrulation [11, 44]. Cubilin contributes ligand-
binding regions of the receptor complex, whereas AMN
ensures the membrane anchorage, biosynthetic processing,
and recycling of the complexes at the plasma membrane
[24]. Interestingly, there was a selective decrease of cubilin
expression in the straight (S3) segment of the PT of Cftr−/−
mice mirrored by an increased urinary excretion of cubilin
ligands such as transferrin and CC16 [43]. Further inves-
tigations demonstrated that the lack of CFTR in the kidney
was not associated with changes in the biosynthesis of
cubilin but, rather, with a significant increase in the
excretion of cubilin in the urine of Cftr−/− mice. No
significant changes in kidney and urine abundance of
megalin were observed. Taken together, these data suggest
that the lack of CFTR in renal PT cells induces instability of
cubilin at the brush border, leading to its accelerated
shedding into urine. Although the lack of suitable reagents
prevented to investigate the specific role of AMN in the
process, it is tempting to hypothesize that such cubilin
instability could be due to the improper processing or
trafficking of one of its partners in relation with the lack of
CFTR in that nephron segment [43].
Renal phenotype in mice and humans harboring
the ΔF508 mutation
The ΔF508 mutation is the most common mutation in the
CF population, with almost 90% of Caucasian CF patients
having at least one ΔF508 allele [73]. This mutation affects
the processing and maturation of CFTR to its fully
glycosylated form [5], with retention of ΔF508-CFTR in
the endoplasmic reticulum (ER) by molecular chaperones
[20] and subsequent degradation via the ubiquitin-protea-
some pathway [87]. However, the ΔF508-CFTR can
essentially function as a cAMP-regulated Cl− channel
both in the ER and at the plasma membrane under distinct
permissive conditions [23, 64]. The processing of ΔF508-
CFTR has been shown to revert to that of wild-type CFTR
as the incubation temperature is reduced [13]. Airway and
gallbladder cells from Cftrtm1Eur mice homozygote for the
ΔF508 mutation show increased cAMP-induced Cl− con-
ductance when cultured at 27°C [23].
The Cftrtm1Eur mouse model expressing the ΔF508
mutant CFTR was generated by double homologous
recombination [21, 82]. Six-week-old mice homozygous
for the ΔF508 mutation (CftrΔF/ΔF) have abnormalities
typical of CF such as growth retardation, focal hypertrophy
of goblet cells in the intestinal crypts, and higher basal
nasal potential difference with reduced response to for-
skolin in trachea and intestine. However, the CftrΔF/ΔF
tissues show a residual Cl− conductance, suggesting that the
mutant ΔF508-CFTR is partially processed and reaches the
plasma membrane. This may explain the minor phenotype
of the CftrΔF/ΔF versus Cftr−/− mice (e.g., absence of lethal
intestinal obstruction). Although such rescue phenomenon
has not been clearly demonstrated thus far in man, residual
Cl− transport activity has also been observed in rectal
biopsies of ΔF/ΔF patients with milder CF phenotype [83].
Moreover, the expression of ΔF508-CFTR in man is tissue-
specific, suggesting that the variable severity of CF in
different organs may reflect heterogeneity of residual
expression [45, 65].
In mouse CftrΔF/ΔF kidney, the mRNA abundance of
ΔF508-CFTR was ∼2-fold reduced in comparison to
controls [43]. The mutant ΔF508-CFTR showed defective
glycosylation, with a large individual variability in its
residual expression in the apical area of PT cells.
Consequently, the renal uptake of radiolabelled 125I-β2-
microglobulin was either unchanged or decreased (∼30%)
in comparison to wild-type mice. In addition, the electrolyte
and water handling has previously been demonstrated as
largely preserved in the PT of Cftrtm2cam ΔF508 mice [49].
Taken together, these data suggest that, in mouse kidney,
the ΔF508-CFTR is variably processed into its mature
form, reaching the plasma membrane and ensuring correct
function in some CftrΔF/ΔF mice.
Clinical and biological investigations of a large cohort of
CF patients, all harboring at least one ΔF508 mutation,
showed a mild but significant albuminuria and LMW
proteinuria versus healthy controls. The specificity of the
LMW proteinuria in CF was supported by the lack of
significant changes in patients with chronic lung inflam-
mation due to active asthma [43]. These findings may
impact on the long-term renal function since LMW
proteinuria can trigger tubulo-interstitial injury progressively
leading to renal failure [2]. Moreover, the increased urinary
loss of the cubilin-ligand, transferrin, could participate in the
iron deficiency and lower circulating transferrin levels that
are commonly reported in CF patients [62, 68].
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Conclusions and perspectives
The spectrum of CF, which was previously considered as a
respiratory and digestive disease associated with a rapidly
fatal outcome, has broadened considerably over the last
decade. Recent studies performed in CF mouse models and
patients with CF have demonstrated that the functional loss
of CFTR is associated with a moderate but significant defect
in LMW protein handling by the kidney. These data support
a role of CFTR in cubilin-mediated endocytic pathway in PT
cells. Data obtained in mice and patients harboring the
ΔF508 mutation also give insights into the tissue-specific
and species-dependent processing of wild-type and mutant
CFTR [63]. Further investigations in different CF mouse
models [30] and in other animal models that may be more
relevant for the disease [72] should help to clarify the role
of CFTR in other specialized kidney functions, such as Ca2+
handling and NaCl homeostasis [17]. One should also
consider that subtle abnormalities in kidney development,
function, and/or morphology may appear in CF patients at a
later stage—as longer survival may be associated with a
potential for developing multi-organ complications [73].
Finally, in addition to the functional loss of CFTR, specific
kidney diseases may involve an abnormal activity or
expression of CFTR. For example, several lines of evidence
have shown that CFTR is upregulated and activated in the
cells lining the cysts, playing a role in cyst fluid accumulation
in autosomal dominant polycystic kidney disease, the most
common inherited nephropathy [14, 35, 56, 65, 88].
Investigation of these situations may also prove useful to
gain knowledge in the role of CFTR during nephrogenesis
and in the mature kidney.
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